Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 10/18/2024
Closing price: 86.72
Support price level: | $80.49 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 66.8 |
Beta | 0.26 |
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$63.15 | $87.36 | 97.7% |
200 day | 50 day | 20 day | 10 day |
$74.03 | $80.95 | $84.75 | $85.71 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
25.8% | 23.8% | 21.5% | 23.1% |
- 5.8% in the next week.
- 13.1% in the next month.
- 45.9% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks